Rankings
▼
Calendar
VSTM Q2 2019 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-68.6% YoY
Gross Profit
$2M
75.5% margin
Operating Income
-$38M
-1220.6% margin
Net Income
-$42M
-1345.5% margin
EPS (Diluted)
$-6.85
QoQ Revenue Growth
+87.7%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$219M
Total Liabilities
$169M
Stockholders' Equity
$49M
Cash & Equivalents
$113M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$10M
-68.6%
Gross Profit
$2M
$10M
-76.3%
Operating Income
-$38M
-$18M
-110.4%
Net Income
-$42M
-$18M
-129.7%
Revenue Segments
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$199,000
48%
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$153,000
37%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$52,000
13%
Product Revenue And Allowances Returns
$8,000
2%
← FY 2019
All Quarters
Q3 2019 →